Coloplast A/S CLPBF
72.70 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
68.55 Day range 69.26
56.81 52-week range 95.43
- YTD
- -13.14%
- 1 year
- -19.65%
- Market cap
- 16.38B
- EPS (ttm)
- 2.12
- P/E ratio
- 34.29
- YTD return
- -13.14%
- 1-year return
- -19.65%
- Volume
- 300
- Avg volume
- 740
- Open
- 69.25
- Previous close
- 72.70
- Day's range
- 68.55 – 69.26
- 52-week range
- 56.81 – 95.43
- Earnings date
- Aug 18, 2026
2Y -57.30 (-44.08%)
Next earnings
Aug 18, 2026
Expected Aug 18, 2026. Consensus EPS estimate 0.933.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 18, 2026 | Jun 30, 2026 | 0.933 | — | — | — |
| May 12, 2026 | Mar 31, 2026 | 0.911 | 0.95 | +0.04 | +4.28% |
| Feb 6, 2026 | Dec 31, 2025 | 0.958 | 0.992 | +0.03 | +3.55% |
| Nov 4, 2025 | Sep 30, 2025 | 0.943 | 0.732 | -0.21 | -22.38% |
| Aug 19, 2025 | Jun 30, 2025 | 0.831 | 0.608 | -0.22 | -26.84% |
| May 6, 2025 | Mar 31, 2025 | 0.773 | 0.629 | -0.14 | -18.63% |
News
Coloplast pares back China operations as market recovery remains elusive
Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says
Coloplast Might Have Found Its Bottom
Coloplast: Went 'BUY' A Bit Early
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
Coloplast: The Market Is Throwing Away A High-Quality Compounder
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Coloplast appoints Gavin Wood as new CEO
Coloplast A/S - Updated Financial Calendar 2025-26
Your note
Sign in to keep a note on CLPBF — it syncs with the Stock Master app.
